Heart MRI study for women with Fabry disease
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study uses heart MRI to look at a specific heart tissue change in women with Fabry disease who have not yet started treatment. It aims to understand if this change could help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 50 years old
- You have been diagnosed with Fabry disease (confirmed by genetic testing)
- You have not started any Fabry disease-specific treatment (like enzyme replacement therapy or migalastat)
- Your heart is not thickened (a recent echocardiogram shows normal heart wall thickness)
- You are not pregnant or breastfeeding
- You have no metal implants or other reasons that make MRI unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early structural and tissue changes in the heart using a special type of MRI scan in adults with Fabry disease. It may help doctors understand changes earlier and better track heart involvement over time.
This study uses advanced heart scans (PET/CT and MRI) to look at inflammation, blood vessel health, and scarring in the hearts of people with Fabry disease. It aims to better understand how Fabry disease affects the heart and find new ways to track or treat these changes.
This study uses MRI scans to look at how Fabry disease affects the kidneys, including scarring, swelling, and oxygen levels. It may help researchers understand kidney problems better and find new ways to monitor the disease.
This study is for people with Fabry disease who are taking or planning to take the medication Elfabrio (pegunigalsidase alfa). It will look at how safe and effective the treatment is in real-world use.
This study checks how your heart’s electrical rhythm looks over a longer period using an ECG (a heart rhythm recording) in people with Fabry disease. It may help doctors understand heart rhythm changes better so future care can be more tailored and safer.
This study looks at new ways to detect and predict heart problems in people with Fabry disease. By participating, you may help improve early diagnosis and care for this condition.
Hear when a new Fabry Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.